Organization
Hospital Clínico San Carlos and IdISSC, Madrid, Spain
2 abstracts
Abstract
Efficacy and safety of trastuzumab deruxtecan (T-DXd) in patients (pts) with HER2-expressing solid tumors: DESTINY-PanTumor02 (DP-02) interim results.Org: Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, Seoul National University College of Medicine, Seoul, Korea, Republic of (South), Cancer Center Clínica Universidad de Navarra, Madrid, Spain, Maria Sklodowska-Curie National Research Institute and Oncology Centre (MSCI), Warsaw, Poland, Hospital Clínico San Carlos and IdISSC, Madrid, Spain,
Abstract
Association of encapsulation of CDK12 inhibitor with anti-tumour activity in colon cancer cell lines.Org: Medical Oncology Department, Presidio Ospedaliero Santa Maria della Misericordia, Azienda Sanitaria Universitaria Friuli Centrale (ASUFC), Udine, Italy, Hospital Universitario Clínico San Carlos, Hospital Clínico San Carlos, Hospital Clínico San Carlos and IdISSC, Madrid, Spain, Instituto de Investigación Sanitaria Hospital Clínico San Carlos (IdISSC),